share_log

Lake Street Initiates Coverage On Silk Road Medical With Buy Rating, Announces Price Target of $20

Lake Street Initiates Coverage On Silk Road Medical With Buy Rating, Announces Price Target of $20

Lake Street以買入評級啓動對絲路醫療的報道,宣佈目標股價爲20美元
Benzinga ·  01/03 11:45

Lake Street analyst Frank Takkinen initiates coverage on Silk Road Medical (NASDAQ:SILK) with a Buy rating and announces Price Target of $20.

湖街分析師弗蘭克·塔基寧以買入評級啓動了對絲綢之路醫療(納斯達克股票代碼:SILK)的報道,並宣佈目標股價爲20美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論